Bio ReFine
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- Undisclosed
Investors
- 1
About Bio ReFine
Based in Israel, Bio ReFine Ltd. operates as a developer of an endovascular annuloplasty remodeling system. The company was founded by its CEO, Boaz Shenhav. Bio ReFine Ltd. Bio ReFine offers medical devices focused on interventional structural cardiology. The firm’s devices address mitral and tricuspid valve regurgitation, a heart condition affecting millions. The company provides a novel implant-less annuloplasty repair technique performed through a catheter for repairing mitral and tricuspid heart valves. The firm utilizes a catheter-based, endovascular procedure to remodel the valve annulus without implanting any foreign material.
Who invested in Bio ReFine
1 investor across 2 rounds
See all investors in Bio ReFine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bio ReFine
Who invested in Bio ReFine?
Bio ReFine has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bio ReFine raised?
Bio ReFine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bio ReFine last raise money?
Bio ReFine's most recent round on record is a Seed, in Oct 2025.
What does Bio ReFine do?
Based in Israel, Bio ReFine Ltd.
Where is Bio ReFine headquartered?
Bio ReFine is headquartered in Israel.
Which VCs invest in companies like Bio ReFine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at Bio ReFine's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Bio ReFine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.